$BBNX News

Beta Bionics Announces Near Real-Time Real-World Data On iLet Bionic Pancreas Is Now Publicly Available At betabionics.com/hcp/real-world-data

Goldman Sachs Maintains Buy on Beta Bionics, Lowers Price Target to $17

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development

Beta Bionics Intends To Fully Commercialize Mint By Q2 2027

B of A Securities Maintains Neutral on Beta Bionics, Lowers Price Target to $11

Beta Bionics, Inc. (BBNX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Leerink Partners Maintains Outperform on Beta Bionics, Lowers Price Target to $24

Stifel Maintains Buy on Beta Bionics, Lowers Price Target to $20

Beta Bionics, Inc. 2026 Q1 - Results - Earnings Call Presentation

Beta Bionics Inc (NASDAQ:BBNX) Beats Q1 2026 Estimates and Raises Full-Year Guidance

Beta Bionics, Inc. (BBNX) Q1 2026 Earnings Call Transcript

Beta Bionics Q1 2026 Earnings Call Transcript

Beta Bionics Raises FY2026 Sales Guidance from $130.000M-$135.000M to $131.000M-$136.000M vs $132.590M Est

Beta Bionics Q1 EPS $(0.49), Inline, Sales $27.626M Beat $26.965M Estimate

Goldman Sachs Maintains Buy on Beta Bionics, Lowers Price Target to $20

Beta Bionics: Speculative Appeal After An Eventful Start To The Year

Beta Bionics Files For Mixed Shelf; Size Not Disclosed

Beta Bionics shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.

Beta Bionics shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.

Stifel Maintains Buy on Beta Bionics, Lowers Price Target to $22